Articles tagged with Cancer Screening
A recent study develops a physicochemical approach to optical biosensing using 1DZnO nanostructures, enabling rapid CYFRA 21-1 testing within a 5-minute detection window. The developed biosensors have the potential to provide accurate and reliable results in complex matrices like saliva.
A cross-sectional study found that including race in disease risk models improves prediction accuracy, but the clinical net benefit is smaller than expected. The researchers provide a widely adaptable framework for deciding whether to include or exclude race from disease risk predictions.
A new study reveals that lung cancer screening CTs can detect coronary artery disease in 83% of cases, with high levels found in 30%. This finding highlights the potential benefits of lung cancer screening for identifying and managing cardiovascular risk factors.
A new study shows that mailing at-home fecal immunochemical testing kits and providing coordinated follow-up led to a tripling of screening completion rates compared to usual care. The intervention increased screening rates by 30% within six months and 34.6% by 12 months.
Achalasia is associated with an increased risk of esophageal squamous cell carcinoma, highlighting the need for close surveillance in high-risk patients. Chronic inflammation and food stasis can lead to malignant transformation, emphasizing the importance of timely intervention.
A recent study has uncovered a genetic variant in the PSA gene that is associated with aggressive prostate cancer. This finding could lead to the development of a novel point-of-care device that can identify high-risk patients with low blood PSA levels, enabling early detection and treatment.
Recent advancements in diagnostic techniques, including artificial intelligence integration, biomarker discoveries, and imaging technologies, have transformed the detection of pancreatic cancer. Key findings include improved sensitivity and accuracy of early-stage lesion identification using AI models, as well as the discovery of novel...
Research highlights the role of gut dysbiosis in pancreatic ductal adenocarcinoma (PDAC), with specific microbial profiles associated with PDAC. Fecal microbiota transplantation (FMT) is proposed as a potential adjunct therapy to improve patient outcomes through microbiome modulation and immune system recalibration.
The National Comprehensive Cancer Network has updated its guidelines for genetic/familial high-risk assessment, incorporating the latest scientific research and expert recommendations to enhance screening practices and treatment options. The expanded guidelines cover various cancer types and provide guidance on genetic testing, heredit...
A new University of Michigan study analyzed 2022 data from Michigan Medicare participants to assess the impact of virtual care on low-value care. The study found that high-telehealth-use clinics did not see a rise in unnecessary tests and scans, while some saw a faster drop in these procedures.
A comprehensive analysis of 52,000 men with prostate cancer treatment found substantial long-term risks of urinary and sexual complications. Men treated with radiotherapy faced a threefold risk of bladder cancer diagnosis, while those who underwent prostatectomy had a sixfold increased risk of complications.
A recent study demonstrates that stool DNA testing is highly sensitive and specific for detecting colorectal cancer among Thai individuals, with a sensitivity of 91.5% and specificity of 90.3%. The test targets methylation statuses of three genes and may provide a viable non-invasive alternative to colonoscopy.
A new study has found that Canadian women who did not identify as White have an earlier peak age of breast cancer diagnosis and higher proportions of cases diagnosed under age 50. They also experience an earlier peak age of death, with a 7-year gap in mortality rates compared to their White counterparts.
A new initiative, CAL-PALS, aims to expand access to life-saving lung cancer screening for marginalized groups in Los Angeles County. The program will engage physicians and staff to create system-level changes increasing access to high-quality services.
A low-dose CT scan can pick up on early-stage lung cancers, which can often be completely removed with surgery. However, less than a fifth of those eligible for the test are getting it, highlighting awareness and communication gaps.
A new survey by Ohio State University shows that most people believe pancreatic disease affects only the elderly and that there is nothing they can do to reduce their risk. However, obesity increases lifetime risk for pancreatic cancer by 20%.
Researchers found that using a multi-step strategy with less-invasive devices can identify patients with Barrett's oesophagus before an endoscopy. This approach is promising for cost-effective screening, which could lead to earlier diagnosis and treatment of oesophageal cancer.
A recent study by Stanford Medicine suggests that new blood-based colon cancer screening tests are effective for people who shun traditional methods. However, if too many switch to the new tests, colorectal cancer death rates may rise due to reduced detection of early cancers and precancerous polyps.
Researchers developed HPV16 peptide microspheres to induce specific cytotoxic T lymphocytes, leading to tumor regression in cervical cancer models. The approach combines peptide-based vaccinations with microsphere technology to enhance immune responses and eliminate tumor cells.
A systematic review and meta-analysis found a significant association between Helicobacter pylori infection and the risk of cardia gastric cancer in Asian countries, with stronger associations observed in East Asia. The study suggests that H. pylori infection is a major risk factor for CGC in this region.
This study reveals a substantial increase in US elderly cutaneous malignant melanoma incidence rates, peaking at 1.53 per 1,000 males and 0.59 per 1,000 females aged 85+ from 2012 to 2016. Incidence rates escalated with age and birth cohort, with continuous increases observed.
A new lung cancer screening initiative in Central Texas has successfully increased screenings among low-income and minority populations. The program's patient-centered approach, including bilingual support and no-cost screenings, resulted in an 83% completion rate of low-dose CT scans among eligible patients.
A new study from the University of Texas at Arlington suggests that analyzing RNA in urine can show changes in cell types, revealing early signs of cancer and other diseases. This method could help clinicians detect problems earlier when they are more easily treated without invasive procedures.
College of Medicine – Tucson researchers are using a $3.3 million grant to test advanced breast computed tomography (CT) scans that create high-resolution 3-D images without physical compression, aiming to enhance early cancer detection and diagnosis for women with dense breasts. The technology has the potential to detect more breast c...
A Kaiser Permanente study found that close to 39% of adults aged 45-49 returned their FIT kit, compared to nearly 38% of adults aged 50. The study suggests that adults in this age group have a similar colorectal cancer risk as those aged 50.
Researchers at Weill Cornell Medicine have developed a virtual screening approach to identify small molecule drug candidates targeting cancer checkpoints. The method successfully identified two compounds with potential therapeutic activity against TIM-3 and VISTA inhibitory checkpoints.
A new study by Concordia researchers found that one-third of adult childhood cancer survivors experience a severe fear of cancer recurrence, which can cause real distress. The study highlights the need for improved treatment and screening for this understudied population.
Cancer incidence recovered significantly in 2021 after substantial disruptions during the COVID-19 pandemic. However, further recovery is needed to address undiagnosed cases and meet healthcare demands.
Researchers identified three genetic regions strongly associated with increased prostate incidence in a diverse group of African men. The study, the largest of its kind in Africa, may lead to new treatment possibilities and refined screening methods.
Gastric cancer is the sixth most common cancer globally, with high incidence rates in Asia, Latin America, and parts of Europe. Screening programs focusing on H. pylori eradication and early detection have shown promise in reducing mortality rates. Emerging research explores serological markers for pre-screening tools and vaccination a...
A study by UC San Francisco found that more screen time is associated with severe symptoms of depression, anxiety, inattention, and aggression in 9-10 year olds. The effects were small but consistent, with activities like video chatting and playing video games strongly linked to depressive symptoms.
A new study published in JAMA Network Open found that racial and ethnic minorities are more likely to have claims for free preventive care denied by insurance plans, leading to unexpected bills or lack of access. Healthcare providers also charge disadvantaged groups a higher amount for preventive services.
Adult childhood cancer survivors experience elevated fear of cancer recurrence, emphasizing the importance of routine screening and timely symptom intervention. The study's findings suggest that fear of cancer recurrence should be a significant concern in survivorship care.
A retrospective cohort study found that AI algorithms can identify women at high risk of developing breast cancer 4-6 years before detection. The results suggest using commercial AI algorithms as a pathway to personalized screening approaches, leading to earlier cancer diagnosis.
A new study aims to increase follow-up care for patients who receive abnormal stool-based fecal immunochemical tests, focusing on improving coordination between primary and specialty clinics. The goal is to improve colorectal cancer screening processes in underserved populations, increasing survival and reducing mortality.
A new study found significant disparities in at-home test use among older adults, with those having a college degree or higher and higher incomes being more likely to use them. However, Black older adults were less likely to use these tests compared to other racial/ethnic groups.
Researchers seek to identify Hispanic women at risk of developing chronic diseases through early screenings or interventions, aiming to improve health outcomes for millions in the population.
Researchers propose reevaluating nomenclature for low-grade prostate cancer, a condition that rarely metastasizes or causes symptoms. This shift aims to balance detection with treatment to reduce harms of overdiagnosis and overtreatment.
According to the Global Cancer Observatory (GLOBOCAN), lung cancer is the most common type of cancer, with 2.2 million new cases and 1.8 million deaths worldwide in 2020. China had the highest number of new cases, and incidence and mortality rates have been steadily rising from 1990 to 2019.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center developed a biobank of 294 samples from 126 patients with 25 different subtypes of bone and soft tissue sarcoma. The team created tumor organoids that retained key characteristics of the original tumors, which were then subjected to high-throughput drug screening. They iden...
A new study published in Radiology journal reveals that advanced 3D mammography detects breast cancer earlier and less often results in false positives compared to traditional digital mammography. This improved detection rate has significant implications for breast cancer diagnosis and treatment.
Researchers found that humorous comic strip cartoons increased likelihood of agreeing to take a quiz on personal risk for colon cancer. Exposing people to funny content reduced information avoidance, making them more likely to choose to watch a video about colorectal cancer prevention.
A 10-year study found that digital breast tomosynthesis increases cancer detection rates and reduces advanced cancers compared to conventional 2D digital mammography. DBT detected more aggressive cancers at an earlier stage than digital mammography, leading to improved cancer detection and lower recall rates.
The COVID-19 pandemic has led to a decrease in cancer diagnosis rates in the US, according to a new study. Despite improved trends in 2021, the rates remain lower than expected, exacerbating the existing deficit of diagnosed cases from 2020.
Generative AI is revolutionizing oncological imaging by expanding datasets and improving image quality. This technology enables predictive oncology and personalized cancer screening, offering new hope in the fight against cancer.
A Mayo Clinic study found that people with monoclonal B-cell lymphocytosis (MBL) have a 92% elevated risk of developing melanoma. MBL is a precursor to chronic lymphocytic leukemia and also increases the risk of cancers originating in the lymphatic system and serious infections.
Researchers have developed an integrated optical sensor capable of detecting dopamine directly from unprocessed blood samples. This breakthrough enables low-cost and efficient screening tools for various neurological conditions and cancers.
A large cohort study found that false-positive mammography results lead to a significant decrease in subsequent screening rates among women. The study, published in Annals of Internal Medicine, highlights the potential unintended consequence of false positives on routine breast cancer screening participation.
Researchers have developed a nanodrug that targets miR-10b, a small noncoding RNA implicated in cancer cell invasion and proliferation. The study shows that inhibiting miR-10b reduces the stemness of breast cancer cells, supporting dedifferentiation as a potential therapeutic mechanism.
Women with regular annual mammograms had higher overall survival and lower late-stage cancer rates than those screened less frequently. The study's findings contradict current guidelines, suggesting a significant benefit to annual screening for women over 40.
Researchers explore AI's role in addressing challenges in immunotherapy, developing new biomarkers for precise disease characterization and predicting treatment response. A comprehensive review applied AI/radiomics to cross-sectional imaging, showcasing the current landscape in IO treatment.
Researchers found that CHEK2 variants do not increase colorectal cancer risk compared to controls. Three low-risk missense variants were identified as potential drivers of breast cancer risk variability.
Esophageal cancer is a major public health concern in China, with late diagnoses contributing to poor prognosis. Early detection through screening methods like endoscopy and biomarker detection has shown significant outcomes, particularly in high-risk areas.
Researchers used low-cost videoscopes to create high-quality 'oral selfies' for OPSCC screening, demonstrating their feasibility and effectiveness. The study's findings support the potential of these devices as a viable tool for widespread screening in resource-limited settings.
The field of cancer immunotherapy is advancing with innovations in precision medicine, including adoptive cell transfer therapy, TCR-engineered T cells, and natural killer cell therapy. Therapeutic vaccines are also being developed to target specific cancer antigens, offering new treatment options for patients.
The review explores the progression of oral leukoplakia to oral squamous cell carcinoma, highlighting genetic and epigenomic alterations, as well as sample collection methods for research and diagnosis. Advances in sequencing technologies and single-cell analyses are providing deeper insights into cancer progression.
The study analyzes six major digestive system cancers worldwide and in China, revealing correlations between country HDI and cancer prevalence. Colorectal cancer is the most prevalent, while Asia accounts for 60.5% of new gastrointestinal cancer cases globally.
Early oral cancer detection improves patient outcomes and reduces mortality. Advanced technologies like imaging and AI enhance the accuracy of traditional screening methods.
Recent advances highlight PIK3CA mutation significance in determining targeted therapy efficacy, particularly in advanced breast cancer. Molecular signatures and genetic profiles drive personalized treatment strategies, with emerging therapies offering new hope for patients.
A clinical trial in Denmark found that offering women further screening opportunities during breast cancer screenings significantly increased their participation and enabled early diagnosis of other cancers. The study used a cluster-randomized crossover design and involved over 27,000 participants.